Difficulty: Medium
Average Score: 75%
Practice
Indicate the drug which is a leucotriene receptor antagonist:
Correct answer
B
Rationale
In the context of pharmacological lifespan treatment, the correct answer to the question is B) Zafirlukast, which is a leukotriene receptor antagonist. Leukotrienes are inflammatory mediators involved in asthma and allergic rhinitis. Zafirlukast works by blocking the action of leukotrienes, thereby reducing inflammation and constriction of the airways.
Option A) Sodium cromoglycate is a mast cell stabilizer used in the treatment of asthma and allergic conditions. It works by preventing the release of inflammatory mediators like histamine and leukotrienes, but it is not a leukotriene receptor antagonist.
Option C) Zileuton is a 5-lipoxygenase inhibitor that also blocks the formation of leukotrienes, but it does so by inhibiting the enzyme involved in their synthesis, rather than acting directly on the receptors like zafirlukast.
Option D) Triamcinolone is a corticosteroid that works by reducing inflammation and suppressing the immune response through multiple mechanisms, but it is not a leukotriene receptor antagonist.
Understanding the mechanisms of action of different drug classes is crucial in pharmacology to make informed decisions in patient care. Knowing which drug targets specific pathways helps in choosing the most appropriate treatment for different conditions. In the case of asthma and allergic conditions, knowing that zafirlukast is a leukotriene receptor antagonist allows for targeted therapy to address the underlying inflammatory processes involved in these conditions, leading to better outcomes for patients.
Option A) Sodium cromoglycate is a mast cell stabilizer used in the treatment of asthma and allergic conditions. It works by preventing the release of inflammatory mediators like histamine and leukotrienes, but it is not a leukotriene receptor antagonist.
Option C) Zileuton is a 5-lipoxygenase inhibitor that also blocks the formation of leukotrienes, but it does so by inhibiting the enzyme involved in their synthesis, rather than acting directly on the receptors like zafirlukast.
Option D) Triamcinolone is a corticosteroid that works by reducing inflammation and suppressing the immune response through multiple mechanisms, but it is not a leukotriene receptor antagonist.
Understanding the mechanisms of action of different drug classes is crucial in pharmacology to make informed decisions in patient care. Knowing which drug targets specific pathways helps in choosing the most appropriate treatment for different conditions. In the case of asthma and allergic conditions, knowing that zafirlukast is a leukotriene receptor antagonist allows for targeted therapy to address the underlying inflammatory processes involved in these conditions, leading to better outcomes for patients.